atropine has been researched along with 4-n-butyl-1-(4-(2-methylphenyl)-4-oxo-1-butyl)-piperidine hydrogen chloride in 2 studies
| Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (4-n-butyl-1-(4-(2-methylphenyl)-4-oxo-1-butyl)-piperidine hydrogen chloride) | Trials (4-n-butyl-1-(4-(2-methylphenyl)-4-oxo-1-butyl)-piperidine hydrogen chloride) | Recent Studies (post-2010) (4-n-butyl-1-(4-(2-methylphenyl)-4-oxo-1-butyl)-piperidine hydrogen chloride) |
|---|---|---|---|---|---|
| 26,711 | 1,259 | 1,697 | 6 | 0 | 4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bang-Andersen, B; Bundgaard, C; Christoffersen, CT; Hentzer, M; Larsen, K; Mikkelsen, GK; Plath, N; Sams, AG | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
2 other study(ies) available for atropine and 4-n-butyl-1-(4-(2-methylphenyl)-4-oxo-1-butyl)-piperidine hydrogen chloride
| Article | Year |
|---|---|
Discovery of N-{1-[3-(3-oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.
Topics: Allosteric Regulation; Animals; Benzeneacetamides; Benzoxazines; Brain; Calcium; Cell Line; Cricetinae; Cricetulus; Female; Hepatocytes; Humans; In Vitro Techniques; Male; Maze Learning; Memory, Short-Term; Mice; Nootropic Agents; Oxazines; Piperidines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Structure-Activity Relationship | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |